← Open Payments lookup

THERESA PUTMAN: Open Payments

NPI 1609114198 · REFORM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,027 in 47 payments from 15 companies in 2025. Trend: 2023 $638 · 2024 $542 · 2025 $1,027

Food & beverage: $1,027
CompanyPaymentsAmount
ABBVIE INC.16$256
Vanda Pharmaceuticals Inc.10$204
Otsuka America Pharmaceutical, Inc.4$150
Novo Nordisk Inc2$117
Indivior Inc.3$66
Ardelyx, Inc.2$43
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$39
Bayer Healthcare Pharmaceuticals Inc.1$26
VERTEX PHARMACEUTICALS INCORPORATED1$23
Neurocrine BioSciences, Inc.1$20

Products named: FANAPT, REXULTI, VRAYLAR, Wegovy, SUBLOCADE, IBSRELA, CAPLYTA, BOTOX.

Industry payments across AL — which companies pay providers there.